The effect of Rivaroxaban on haemostasis assays; results from ECAT surveys

In Newsletter 5 of June 2015 P. Meijer (ECAT Foundation, Leiden, The Netherlands) described the effect of rivaroxaban on haemostasis assays.

Related items

Guidelines : 4

Cases : 12

Analytical Information : 12

Test Information : 17

Quality Issues : 9

Haemostatic Cascade : 6

Factor VIII Inhibitor : 2

Clotting factor (II, V, VII and X) : 4

Clotting factor (VIII, IX, XI and XII) : 7

Thrombophilia : 9

Screening : 2